Tremor in Parkinson’s disease and essential tremor: practical aspects of differential diagnosis
https://doi.org/10.21518/2079-701X-2019-9-46-54
Abstract
Despite the developed criteria of essential tremor (ET) and Parkinson’s disease (PD), clinical practice shows a high percentage of misdiagnoses, especially in the early stages of the disease and during the patient’s initial contact with a neurologist. In addition, the same patient may have signs of ET and PD at the same time. For a correct diagnosis, a detailed clinical examination is necessary. The specific characteristics of tremor (frequency, amplitude, type, involvement of specific parts of the body), history, associated neurological signs, and concomitant non-motor symptoms help to recognize and distinguish these two diseases. In order to exclude the possible negative effect of concomitant medications on tremor, it is necessary to find out about the medication history. The article offers an algorithm of survey and inspection, as well as the interpretation of the data obtained. In diagnostically complicated cases, «trial» therapy is carried out. Additional information for differential diagnosis can be provided by the results of instrumental methods of investigation of transcranial sonography of black substance and single-photon emission computed tomography (DaTSCAN).
About the Authors
N. V. TitovaRussian Federation
Cand. of Sci. (Med), Associate Professor of the Department of Neurology, Neurosurgery and Medical Genetics of the Medical Faculty of the Federal State Budgetary Educational Institution of Higher Education «Russian National Research Medical University named after N.I. Pirogov» of the Ministry of Health of the Russian Federation.
Yu. N. Bezdolny
Russian Federation
Cand. of Sci. (Med), Neurologist of the State Budgetary Healthcare Institution of Moscow «Moscow Polyclinic №107 of the Moscow City Healthcare Department».
I. V. Shtuchny
Russian Federation
Student of the Federal State Budgetary Educational Institution of Higher Education «Russian National Research Medical University named after N.I. Pirogov» of the Ministry of Health of the Russian Federation.
D. A. Sibetsky
Russian Federation
Student of the Federal State Budgetary Educational Institution of Higher Education «Russian National Research Medical University named after N.I. Pirogov» of the Ministry of Health of the Russian Federation.
References
1. Deuschl G., Petersen I., Lorenz D., Christensen K. Tremor in the elderly: Essential and agingrelated tremor. Mov Disord. 2015;30(10):1327-1334.
2. de Rijk M.C., Breteler M.M.B., Graveland G.A., Ott A., Grobbee D.E., van der Meche F.G.A., Hofman A. Prevalence of Parkinson’s disease in the elderly: The Rotterdam Study. Neurology. 1995;45(12):2143-2146.
3. Bhatia K.P., Bain P., Bajaj N., Elble R.J., Hallett M, Louis ED, et al; Tremor Task Force of the International Parkinson and Movement Disorder Society. Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord. 2018;33(1):75-87.
4. Postuma R.B., Berg D., Stern M., Poewe W., Olanow C.W., Oertel W., et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30(12):1591-1601.
5. Jain S., Lo S.E., Louis E.D. Common misdiagnosis of a common neurological disorder: how are we misdiagnosing essential tremor? Arch. Neurol. 2006, 63(8): 1100-1104.
6. Schrag A., Münchau A., Bhatia K.P., Quinn N.P., Marsden C.D. Essential tremor: an overdiagnosed condition? J Neurol. 2000;247(12):955-959.
7. Thenganatt M.A., Louis E.D. Distinguishing essential tremor from Parkinson’s disease: bedside tests and laboratoryevaluations. Expert Rev Neurother. 2012;12(6):687-696.
8. Algarni M., Fasano A. The overlap between Essential tremor and Parkinson disease. Parkinsonism Relat Disord. 2018;46(1):S101-S104.
9. Espay A.J., Lang A.E., Erro R., Merola A., Fasano A., Berardelli A., et al. Essential pitfalls in «essential» tremor. Mov Disord. 2017;32(3):325-331.
10. Hanajima R., Tsutsumi R., Shirota Y., Shimizu T., Tanaka N., Ugawa Y. Cerebellar dysfunction in essential tremor. Mov Disord. 2016;31(8):1230-1234.
11. Alty J., Cosgrove J., Thorpe D., Kempster P. How to use pen and paper tasks to aid tremor diagnosis in the clinic. Pract Neurol. 2017;17(6):456-463
12. Титова Н.В., Чаудури K.Р. Немоторные симптомы болезни Паркинсона: подводная часть айсберга. Анналы клинической и экспериментальной неврологии. 2017;11(4):5-18. [Titova N.V., Chaudouri K.R. Nonmotor symptoms of Parkinson’s disease: the underwater part of the iceberg. Annaly klinicheskoj i eksperimental’noj nevrologii.2017;11(4):5-18.] (In Russ.)
13. Шипилова Н.Н., Титова Н.В., Катунина Е.А. Проблема немоторных симптомов при болезни Паркинсона и влияние дофаминергической терапии на их коррекцию. РМЖ. 2018;4(II):85-90. [Shipilova N.N., Titova N.V., Katunina E.A. The problem of non-motor symptoms in Parkinson’s disease and the effect of dopaminergic therapy on their correction. RMZh.2018;4(II):85-90.] (In Russ.)
14. Berg D., Postuma R.B., Adler C.H., Bloem B.R., Chan P., Dubois B., et al. MDS research criteria for prodromal Parkinson’s disease. Mov Disord. 2015;30(12):1600-1611.
15. Postuma R.B., Arnulf I., Hogl B., Iranzo A., Miyamoto T., Dauvilliers Y., et al. A singlequestion screen for rapid eye movement sleep behavior disorder: a multicenter validation study. Mov Disord. 2012;27(7):913-916.
16. Postuma R.B., Gagnon J.F., Bertrand J.A., Génier Marchand D., Montplaisir J.Y. Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials. Neurology. 2015;84(11):1104-1113.
17. Postuma R.B., Iranzo A., Hogl B., Arnulf I., Ferini-Strambi L., Manni R., et al. Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Ann Neurol. 2015;77(5):830-839.
18. Foster N.L., Newman R.P., LeWitt P.A., Gillespie M.M., Chase T.N. Treatment of resting tremor by beta-adrenergic blockade. Am. HeartJ. 1984;108(4 Pt 2):1173-1177.
19. Elias W.J., Shah B.B. Tremor. JAMA. 2014;311(9):948-954.
20. Benito-Leon J., Louis E.D., Bermejo-Pareja F. Neurological Disorders in Central Spain Study Group. Risk of incident Parkinson’s disease and parkinsonism in essential tremor: a population based study. J Neurol Neurosurg Psychiatry. 2009;80(4):423-425.
21. Chaudhuri K.R., Buxton-Thomas M., Dhawan V., Peng R., Meilak C., Brooks D.J. Long duration asymmetrical postural tremor is likely to predict development of Parkinson’s disease and not essential tremor: clinical follow up study of 13 cases. J Neurol Neurosurg Psychiatry. 2005;76(1):115-117.
22. Wolters A., Walter U., Wittstock M., Benecke R. Asymmetric postural tremor preceding DOPAresponsive Parkinsonism – the transition disease. J Parkinsons Dis. 2014;4(1):45-55.
23. Karas B.J., Wilder B.J., Hammond E.J., Bauman A.W. Valproate tremors. Neurology. 1982;32(4):428-432.
24. Vestergaard P. Clinically important side effects of long-term lithium treatment: a review. Acta Psychiatr Scand Suppl. 1983;305:1-36.
25. Bhidayasiri R. Differential diagnosis of common tremor syndromes. Postgrad Med J. 2005;81(962):756-762.
26. Miguel R., Correia A.S., Bugalho P. Iatrogenic parkinsonism: the role of flunarizine and cinnarizine. J Parkinsons Dis. 2014;4(4):645-649.
27. Benvenuti F., Baroni A., Bandinelli S., Ferrucci L., Corradetti R., Pantaleo T. Flunarizineinduced parkinsonism in the elderly. J Clin Pharmacol. 1988;28(7):600-608.
28. Garcıa-Ruiz P.J., Garcıa de Yebenes J., JimenezJimenez F.J., Vazquez A., Garcıa Urra D., Morales B. Parkinsonism associated with calcium channel blockers: A prospective follow-up study. Clin Neuropharmacol. 1992;15(1):19-26.
29. Jimenez-Jimenez F.J., Ortı-Pareja M., AyusoPeralta L., Gasalla T., Cabrera-Valdivia F., Vaquero A. et al. Drug-induced parkinsonism in a movement disorders unit: A four-year survey. Parkinsonism Relat Disord. 1996;2(3):145-149.
30. Negrotti A., Calzetti S. A long-term follow-up study of cinnarizine- and flunarizine-induced parkinsonism. Mov Disord. 1997;12(1):107-110.
31. Garcıa-Ruiz P.J., Jimenez-Jimenez F., Garcıa de Yebenes J. Calcium channel blocker-induced parkinsonism: Clinical features and comparisons with Parkinson’s disease. Parkinsonism Relat Disord. 1998;4(4):211-214.
32. Budygin E.A., Gainetdinov R.R., Titov D.A., Kovalev G.I. The effect of a low dose of piracetam on the activity of the dopaminergic system in the rat striatum. Eksp Klin Farmakol. 1996;59(2):6-8.
33. Zaitone S.A., Abo-Elmatty D.M., Elshazly S.M. Piracetam and vinpocetine ameliorate rotenone-induced Parkinsonism in rats. Indian J Pharmacol. 2012;44(6):774-779.
34. Титова Н.В. Возможности применения фиксированной комбинации пирацетама и циннаризина в неврологической практике. Медицинский совет. 2017;10:102-109. [Titova N.V. Possibilities of using a fixed combination of piracetam and cinnarisine in neurological practice. Medicinskij sovet.2017;10:102-109.] (In Russ.)
35. Berg D., Behnke S., Walter U. Application of transcranial Sonographyin extrapyramidal disorder: Updated Recommendation. Ultraschall Med. 2006;27(1):12-19.
36. Walter U., Behnke S., Eyding J., Niehaus L., Postert T., Seidel G., et al. Transcranial brain parenchyma sonography in movement Disorders: state of the art. Ultrasound Med. 2007;33(1):15-25.
37. Asenbaum S., Pirker W., Angelberger P., Bencsits G., Pruckmayer M., Brucke T. [123I] beta-CIT and SPECT in essential tremor and Parkinson’s disease. J Neural Transm. 1998;105(10-12):1213-1228.
38. Benamer T.S., Patterson J., Grosset D.G., Booij J., de Bruin K., van Royen E., et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FPCIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord. 2000;15(3):503-510.
39. Grosset D., Taurah L., Burn D.J., MacMahon D., Forbes A., Turner K., et al. A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson’s disease left untreated at diagnosis. J Neurol Neurosurg Psychiatry. 2007;78(5):465-469.
Review
For citations:
Titova NV, Bezdolny YN, Shtuchny IV, Sibetsky DA. Tremor in Parkinson’s disease and essential tremor: practical aspects of differential diagnosis. Meditsinskiy sovet = Medical Council. 2019;(9):46-54. (In Russ.) https://doi.org/10.21518/2079-701X-2019-9-46-54